Suppr超能文献

弗雷明汉心脏研究中初诊心房颤动患者的特定病因死亡率的时间趋势。

Temporal trends in cause-specific mortality among individuals with newly diagnosed atrial fibrillation in the Framingham Heart Study.

机构信息

Preventive Medicine and Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.

Boston University's and National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA.

出版信息

BMC Med. 2021 Jul 29;19(1):170. doi: 10.1186/s12916-021-02037-x.

Abstract

BACKGROUND

All-cause mortality following atrial fibrillation (AF) has decreased over time. Data regarding temporal trends in causes of death among individuals with AF are scarce. The aim of our study was to analyze temporal trends in cause-specific mortality and predictors for cardiovascular (CVD) and non-CVD deaths among participants with incident AF in the Framingham Heart Study.

METHODS

We categorized all newly diagnosed AF cases according to age at AF diagnosis (< 70, 70 to < 80, and ≥ 80 years) and epoch of AF diagnosis (< 1990, 1990-2002, and ≥ 2003). We followed participants until death or the last follow-up. We categorized death causes into CVD, non-CVD, and unknown causes. For each age group, we tested for trends in the cumulative incidence of cause-specific death across epochs. We fit multivariable Fine-Gray models to assess subdistribution hazard ratios (HR) between clinical risk factors at AF diagnosis and cause-specific mortality.

RESULTS

We included 2125 newly diagnosed AF cases (mean age 75.5 years, 47.8% women). During a median follow-up of 4.8 years, 1657 individuals with AF died. There was evidence of decreasing CVD mortality among AF cases diagnosed < 70 years and 70 to < 80 years (p < 0.001) but not ≥ 80 years (p = 0.76). Among the cases diagnosed < 70 years, the cumulative incidence of CVD death at 75 years was 67.7% in epoch 1 and 13.9% in epoch 3; among those 70 to < 80 years, the incidence at 85 years was 58.9% in epoch 1 and 18.9% in epoch 3. Advancing age (HR per 1 SD increase 6.33, 95% CI 5.44 to 7.37), prior heart failure (HR 1.49, 95% CI 1.14-1.94), and prior myocardial infarction (HR 1.44, 95% CI 1.15-1.80) were associated with increased rate of CVD death.

CONCLUSIONS

In this community-based cohort, CVD mortality among AF cases decreased over time. Most deaths in individuals with AF are no longer CVD-related, regardless of age at AF diagnosis.

摘要

背景

心房颤动(AF)后的全因死亡率随时间推移而降低。关于 AF 患者死亡原因的时间趋势的数据很少。我们研究的目的是分析弗雷明汉心脏研究中首发 AF 患者的特定病因死亡率的时间趋势和心血管(CVD)和非 CVD 死亡的预测因素。

方法

我们根据 AF 诊断时的年龄(<70 岁、70 岁至<80 岁和≥80 岁)和 AF 诊断的时间范围(<1990 年、1990-2002 年和≥2003 年)对所有新发 AF 病例进行分类。我们随访参与者直至死亡或最后一次随访。我们将死亡原因分为 CVD、非 CVD 和未知原因。对于每个年龄组,我们检验了各时间范围内特定病因死亡的累积发生率的趋势。我们使用多变量 Fine-Gray 模型来评估 AF 诊断时临床危险因素与特定病因死亡率之间的亚分布危险比(HR)。

结果

我们纳入了 2125 例新发 AF 病例(平均年龄 75.5 岁,47.8%为女性)。在中位随访 4.8 年期间,1657 例 AF 患者死亡。<70 岁和 70 岁至<80 岁诊断的 AF 患者的 CVD 死亡率呈下降趋势(p<0.001),但≥80 岁诊断的患者则没有(p=0.76)。在<70 岁诊断的患者中,75 岁时 CVD 死亡的累积发生率在第 1 个时间范围为 67.7%,在第 3 个时间范围为 13.9%;在 70 岁至<80 岁诊断的患者中,85 岁时的发生率在第 1 个时间范围为 58.9%,在第 3 个时间范围为 18.9%。年龄增长(每增加 1 个标准差的 HR 为 6.33,95%CI 为 5.44 至 7.37)、既往心力衰竭(HR 为 1.49,95%CI 为 1.14-1.94)和既往心肌梗死(HR 为 1.44,95%CI 为 1.15-1.80)与 CVD 死亡风险增加相关。

结论

在这个基于社区的队列中,AF 患者的 CVD 死亡率随时间推移而降低。无论 AF 诊断时的年龄如何,AF 患者的大多数死亡不再与 CVD 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c228/8320026/512821487ee0/12916_2021_2037_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验